Emory Integrated Genomics Core

埃默里综合基因组学核心

基本信息

  • 批准号:
    10595761
  • 负责人:
  • 金额:
    $ 15.29万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-04-07 至 2023-03-31
  • 项目状态:
    已结题

项目摘要

EMORY INTEGRATED GENOMICS SHARED RESOURCE PROJECT SUMMARY/ ABSTRACT The Emory Integrated Genomics Core Shared Resource (Genomics SR; Categories 1.16, 1.21, and 1.35) provides services allowing scientists to conduct deep genomic sequencing, probe gene expression and methylation patterns in a tissue sample, or search for mutations in an individual's DNA or in a tumor. The central mission of this facility as a Winship shared resource is to support the research efforts of Winship members by providing exceptional cancer genomics services Genomics SR provides services in research and CLIA settings which include nucleic acid extraction, Illumina sequencing, high-density microarray services on both the Affymetrix and Illumina platforms, targeted enrichment, and single nucleotide polymorphism (SNP) genotyping. Significant improvements in shared resource organization and efficiency have increased capacity, lowered costs, and increased service offerings. Service offerings for Illumina next generation sequencing (NGS) have dramatically increased after the adoption of a broker model in which all large-scale service requests are competitively outsourced to one of several academic or commercial vendors. New services, including microbiome and single cell services, have been launched for Winship members. Genomics SR has maintained its CLIA license (CLIA: 11D1086150) and developed closer ties with the Emory Genetics Laboratory, which is now offering clinical cancer diagnostic testing. Improved access to computational resources through the Emory Integrated Computational Core (EICC) and increased collaboration with Winship’s Biostatistics and Bioinformatics Shared Resource (BBISR) have significantly enhanced the analysis of large-scale genomics data sets by Winship members. As a consequence of these changes, usage by Winship members have significantly increased during the current funding period. Genomics SR currently provides valuable services in support of Winship discovery and is well positioned to adopt novel genomic services which will advance Winship research.
Emory集成基因组学共享资源 项目摘要/摘要 Emory集成基因组学核心共享资源(基因组学SR;类别1.16、1.21和1.35) 提供服务,允许科学家进行深入的基因组测序,探测基因表达和 组织样本中的甲基化模式,或搜索个人DNA或肿瘤中的突变。中环 该设施作为Winship共享资源的使命是通过以下方式支持Winship成员的研究工作 提供卓越的癌症基因组学服务基因组学SR在研究和CLIA环境中提供服务 其中包括核酸提取、光照测序、高密度微阵列服务 Affymetrix和Illumina平台、靶向浓缩和单核苷酸多态(SNP)基因分型。 在共享资源组织和效率方面的重大改进增加了容量,降低了成本, 和更多的服务提供。Illumina下一代测序(NGS)服务产品包括 在采用代理模型后显著增加,在该模型中,所有大规模服务请求 竞争性地外包给几家学术或商业供应商之一。新服务,包括 微生物群和单细胞服务已经为Winship成员推出。基因组学SR坚持认为 它的CLIA许可证(CLIA:11D1086150),并与埃默里遗传实验室建立了更紧密的联系,后者是 现在提供临床癌症诊断测试。通过Emory改进对计算资源的访问 集成计算核心(EICC)并加强与Winship的生物统计和 生物信息学共享资源(BBISR)显著提高了大规模基因组数据的分析能力 由Winship成员提供的套装。由于这些变化,Winship成员的使用量显著增加 在本供资期间增加了。基因组学SR目前提供有价值的服务,以支持 Winship发现,并处于有利地位,采用新的基因组服务,将推动Winship的研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Christopher D Scharer其他文献

Christopher D Scharer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Christopher D Scharer', 18)}}的其他基金

Epigenetic instruction of memory B cell function and reactivation
记忆 B 细胞功能和重新激活的表观遗传指令
  • 批准号:
    10308049
  • 财政年份:
    2019
  • 资助金额:
    $ 15.29万
  • 项目类别:
Epigenetic instruction of memory B cell function and reactivation
记忆 B 细胞功能和重新激活的表观遗传指令
  • 批准号:
    10529329
  • 财政年份:
    2019
  • 资助金额:
    $ 15.29万
  • 项目类别:
Core B
核心B
  • 批准号:
    10621324
  • 财政年份:
    2016
  • 资助金额:
    $ 15.29万
  • 项目类别:
Core B
核心B
  • 批准号:
    10428166
  • 财政年份:
    2016
  • 资助金额:
    $ 15.29万
  • 项目类别:

相似海外基金

Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 15.29万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 15.29万
  • 项目类别:
    Collaborative R&D
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 15.29万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 15.29万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 15.29万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 15.29万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 15.29万
  • 项目类别:
    Operating Grants
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 15.29万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 15.29万
  • 项目类别:
    EU-Funded
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 15.29万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了